🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Refractory Chronic Cough

The Real-world Treatment Satisfaction by Gefapixiant in RCC NCT06542484NA2 sites📍 Nagoya📍 Nagoya Nagoya City University · Tests: Gefapixant Citrate Investigating the Role of ATP Production by Airway Epithelium in Patients With Refractory and Unexplained Chronic Cough (RCC/UCC). NCT06600646n/a1 site📍 Hamilton McMaster University · Tests: Bronchoscopy A Study to Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic Cough NCT07690059Phase 23 sites📍 Belfast📍 London📍 London Sensory Cloud, Inc. · Tests: SC0032, Placebo Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough NCT05110144Phase 21 site📍 Rochester Mayo Clinic · Tests: Duloxetine 30 MG, Duloxetine 60 MG, Amitriptyline 25 MG, Amitriptyline 50 MG, Placebo 30 MG Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough NCT05120934Phase 21 site📍 Rochester Mayo Clinic · Tests: Amitriptyline 25 MG, Amitriptyline 50 MG, Duloxetine 30 MG, Duloxetine 60 MG, Placebo 30 MG Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough NCT06960759Phase 23 sites📍 Aurora📍 Atlanta📍 Missoula University of Montana · Tests: BCS+inactive, BCS+active A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension NCT07650084Phase 338 sites📍 Leshan📍 Beijing📍 Changsha GlaxoSmithKline · Tests: BLU-5937, Placebo The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC) NCT07671924Phase 210 sites📍 Toronto📍 Ajax📍 Burlington Trevi Therapeutics · Tests: NAL ER, Placebo Cough Management Wellness App for Refractory or Unexplained Chronic Cough NCT07070895NA1 site📍 Wilmington Hyfe Inc · Tests: Cough Management, CoughMonitor Suite Efficacy of Behavioral Therapy for Chronic Refractory Cough NCT07488598NA1 site📍 Asyut Assiut University · Tests: Behavioral Therapy Laryngeal Cryotherapy for Refractory Neurogenic Cough NCT05665244n/a1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Laryngeal cryotherapy, Cryoprobe
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy